Beyond Efficiency: What Deserves to Be Created? | Booming Club Round Two Recruitment
Beyond work, into wonder & fun.
蓝驰创投
@lanchi
不被定义
371 articles
Articles
BlueRun Ventures Leads OriginFlow's Angel Round, OriginFlow Tackles Embodied Intelligence Data Bottleneck with NeuroScale Paradigm | BlueRun Family
Developing a new proprietary data collection paradigm to help embodied intelligence break through the industry's development bottlenecks.
BlueRun Ventures Leads Oversubscribed $10M+ Angel Round for Naosi Technology, Focusing on Invasive Brain-Computer Interfaces and Neural Foundation Models | BlueRun Family
AI decoding and advanced electrodes are pushing brain-computer interfaces toward real-world applications.
We Met a Bunch of "Unfocused" Weirdos Who Actually Shine | Booming Club Round One
Turns out, every persistence that goes ununderstood will eventually find its resonant echo.
BlueRun Ventures Leads Angel Round in StarSight Technology, Which Focuses on AI-Powered Long-Range Observation | BlueRun Portfolio
From "being able to shoot" to "shooting well," and then to "shooting with meaning."
BlueRun Ventures Portfolio Company NeoImmuneTech Completes $38 Million Financing to Advance First-in-Class "Myeloid Cell Engager" Immunotherapy Pipeline | BlueRun Family
From Technical Platform Validation to Clinical Value
Terry Zhu in Conversation with Yao Xin: In the AI Era, the Biggest Competitive Edge Isn't Technology — It's Speed of Evolution | Booming Talk EP05
Know the mistake, be willing to fix it, fix it fast.
BlueRun Ventures Early-Stage Portfolio Company Shian Biosciences Enters Exclusive ALK7 siRNA Licensing Agreement with GSK | BlueRun Ventures Family Headlines
Attempting to tackle risk management from more fundamental pathological links.
After Breaking Ground, Growth Follows | Quarterly
The stage is set. Your entrance awaits.
ClawCon's China Debut: A Week of Immersive AI with BlueRun Ventures and muShanghai
In Shanghai, Witnessing a Collective Resonance Among AI Creators